0001493152-26-016858
SEC filingCDT Equity Inc. reported significantly wider operating and net losses in FY2025 compared to FY2024, with operating income declining to -$36.8M and net income to -$39.2M — driven by the inherent challenges of executing a lean, disease-agnostic development model amid escalating legal contingencies and public-company infrastructure demands.
We evaluate, on a quarterly basis, developments in legal proceedings and other matters that could cause an increase or decrease in the amount of the liability that has been accrued previously or modifications to contingency disclosures that are considered material. This disciplined, recurring assessment underpins the recognition and measurement of litigation-related liabilities — a key driver of the year’s financial deterioration. While the magnitude and timing of such accruals are inherently uncertain, the process itself is embedded in the Company’s financial controls and disclosure framework.
Operating with a lean disease-agnostic model, CDT Equity prioritizes speed, adaptability, and capital efficiency. This approach deliberately constrains fixed infrastructure but places heightened reliance on external partnerships and targeted investments — a posture that amplifies sensitivity to one-time events like litigation outcomes or financing milestones. The widening losses in FY2025 occurred within this context, not despite it: the model enables rapid iteration but does not insulate against material adverse developments requiring significant accruals or restructuring.
Our historical results are not necessarily indicative of the results that may be expected for any period in the future. We anticipate that our general and administrative expenses will increase substantially for the foreseeable future as we increase our administrative headcount to operate as a public company and as we advance clinical assets through clinical development. This outlook reinforces that FY2025’s financial profile reflects both transitional costs and enduring strategic choices — not a temporary deviation from a stable baseline.